Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Françoise Blanchet is active.

Publication


Featured researches published by Françoise Blanchet.


American Journal of Cardiology | 1985

Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy

Alain Nitenberg; Jean-Marc Foult; Françoise Blanchet; Samir Zouioueche

Coronary sinus blood flow (ml/100 g left ventricular [LV] mass/min) and coronary resistance (mean aortic minus LV mean diastolic pressures/coronary sinus blood flow, mm Hg/[ml/100 g/min]) were studied in 7 control patients and in 11 patients with severe dilated cardiomyopathy (DC) and normal coronary arteriograms. Basal coronary sinus blood flow was not different in the 2 groups. After intravenous administration of dipyridamole (0.14 mg/kg/min X 4 min), coronary sinus blood flow and dipyridamole/basal coronary sinus blood flow ratio were significantly (p less than 0.001) lower in the DC group than in the normal group (coronary sinus blood flow 188 +/- 48 vs 408 +/- 58, respectively; blood flow ratio 1.78 +/- 0.35 vs 4.01 +/- 0.56, respectively), and the coronary resistance was higher in the DC group than in the control group (0.39 +/- 0.15 vs 0.22 +/- 0.03, respectively, p less than 0.01). After administration of dipyridamole in patients with DC, no correlation could be found between coronary sinus blood flow and LV mean diastolic, mean aortic or coronary driving pressures, i.e., mean aortic minus LV mean diastolic pressures. Thus, in DC patients, neither an elevated LV diastolic pressure nor a low coronary perfusion pressure can totally account for the restriction of the coronary flow reserve after dipyridamole.


Journal of the American College of Cardiology | 1988

Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries

Alain Nitenberg; Jean-Marc Foult; Isabelle Antony; Françoise Blanchet; Mohamed Rahali

Left ventricular hypertrophy has been found to be associated with a reduction of coronary vascular reserve, which could be responsible for episodes of myocardial ischemia. To evaluate coronary flow and resistance reserve in patients with chronic aortic regurgitation, coronary sinus blood flow and coronary resistance were measured before and after an intravenous dipyridamole infusion (0.14 mg/kg per min X 4 min) in eight control subjects and eight patients with aortic regurgitation, exertional angina pectoris and normal coronary arteriograms. Coronary flow reserve, evaluated by the dipyridamole/basal coronary sinus blood flow ratio, and coronary resistance reserve, evaluated by the basal/dipyridamole coronary resistance ratio, were both significantly reduced in patients with aortic regurgitation (1.67 +/- 0.40 versus 4.03 +/- 0.52 in control subjects, p less than 0.001 and 1.71 +/- 0.50 versus 4.38 +/- 0.88 in control subjects, p less than 0.001, respectively). In patients with aortic regurgitation, basal coronary sinus blood flow was higher than in control subjects (276 +/- 81 versus 105 +/- 24 ml/min, respectively, p less than 0.001) and basal coronary resistance was lower (0.31 +/- 0.13 versus 0.95 +/- 0.17 mm Hg/ml per min, respectively, p less than 0.001), but coronary blood flow and resistance after dipyridamole were not significantly different in the two groups (461 +/- 159 versus 418 +/- 98 ml/min in control subjects, 0.19 +/- 0.11 versus 0.22 +/- 0.04 mm Hg/ml per min in control subjects, respectively). These data demonstrate that coronary reserve is severely reduced in patients with chronic aortic regurgitation and exertional angina.(ABSTRACT TRUNCATED AT 250 WORDS)


American Journal of Hypertension | 1997

Pressure-Heart Rate Responses to α-Adrenergic Stimulation and Hormonal Regulation in Normotensive Patients With Obstructive Sleep Apnea

Dominique Maillard; Françoise Fineyre; Didier Dreyfuss; Kamel Djedaini; Françoise Blanchet; Frédéric Paycha; Jean-Claude Dussaule; Alain Nitenberg

Seven normotensive untreated patients with obstructive sleep apnea (OSA) and five control subjects without OSA were compared. Patients with cardiac dilation, chronic airflow limitation, liver and kidney disease, or diabetes mellitus were excluded. Change in pressure-heart rate relation to alpha-adrenergic stimulation (P-HRR), extracellular volume (ECV), and plasma volume (Vp) were measured during daytime. Plasma atrial natriuretic peptide (ANP), plasma renin and aldosterone concentrations were obtained at 1 hour intervals during the night. A mean apnea/hypopnea index (AHI) of 52.2 +/- 23.9/h and a mean lowest arterial oxygen saturation (SaO2) of 61.2 +/- 19.3% (mean +/- SD) were determined from polysomnographic monitoring in the patient group. Release of ANP was significantly higher during sleep in OSA patients than in control subjects (P < .01), with a maximum concentration between 4 and 6 AM in the former. Daytime ECV was significantly higher (P < .05) and Vp significantly lower (P < .05) in OSA patients. Night maximum concentration of ANP (max ANP) was negatively related to AHI (P < .05). P-HRR was negatively related to AHI (P < .05) and positively related to max ANP (P < .05). In conclusion, OSA syndrome alters hormonal system control of body fluid compartment regulation. The decreased response in night max ANP secretion in the most severe OSA patients could be explained by the smaller Vp observed in these patients, decreasing atrial and ventricular pressure loading. Furthermore, alteration of P-HRR, correlated to AHI and max ANP, strengthens the hypothesis that patients who develop hypertension are those in whom the protective mechanism of ANP release failed.


Advances in Experimental Medicine and Biology | 1987

Nephrogenic Diabetes Insipidus and Distal Tubular Acidosis in Methicillin-Induced Interstitial Nephritis

Ph. Vigeral; Alain Kanfer; Sabine Kenouch; Françoise Blanchet; Béatrice Mougenot; J. Ph. Méry

Acute interstitial nephritis associated with methicillin therapy has been reported in over 100 patients (1) and new cases are usually no more reported. Although its clinical picture has been extensively described (2–5), little attention has been paid to the possible occurrence of functional impairment of the distal tubule. This report deals with two patients with methicillin-induced interstitial nephritis and renal failure in whom distal tubular abnormalities were prominent.


Nephron | 1997

Evaluation of renal acidification in HIV-infected patients with hypergammaglobulinemia

Marie-Laure Seux-Levieil; Véronique Joly; Patrick Yeni; Claude Carbon; Françoise Blanchet

Distal renal tubular acidosis has been reported in several diseases associated with hypergammaglobulinemia, particularly Sjögrens syndrome. Since HIV infection is now a common cause of hypergammaglobulinemia, we evaluated renal acidification under basal and dynamic conditions in 8 asymptomatic HIV-seropositive subjects. Basal acid-base status was normal in all except 1 patient who had respiratory acidosis subsequent to recent pneumonia. Acid-loading tests showed normal acid excretion except for 1 patient who had low acid excretion attributed to non-ingestion of the ammonium chloride capsules. Bicarbonate-loading tests showed normal distal acidification indexes in 7 patients. The only patient with a low acidification defect was diagnosed 2 weeks later as having tuberculosis. Our results suggest that hypergammaglobulinemia per se is not a sufficient condition to induce renal tubular acidosis.


Chest | 1990

Fiberoptic Bronchoscopy in Ventilated Patients* Evaluation of Cardiopulmonary Risk under Midazolam Sedation

Jean-Louis Trouillet; Marguerite Guiguet; Claude Gibert; Jean-Yves Fagon; Didier Dreyfuss; Françoise Blanchet; Jean Chastre


Nephrology Dialysis Transplantation | 2007

Cardiovascular remodelling and extracellular fluid excess in early stages of chronic kidney disease

Marie Essig; Brigitte Escoubet; Dominique de Zuttere; Françoise Blanchet; Florence Arnoult; Emmanuel Dupuis; Catherine Michel; Françoise Mignon; Christine Clerici; François Vrtovsnik


Kidney International | 1984

Relative contribution of intrinsic lung dysfunction and hypoventilation to hypoxemia during hemodialysis

Françoise Blanchet; Alain Kanfer; Elizabeth Cramer; Abdelaziz Benyahia; Robert Georges; Jean-Philippe Méry; C. Amiel


Journal of Acquired Immune Deficiency Syndromes | 2007

Is phosphatemia the best tool to monitor renal tenofovir toxicity

Marie Essig; Xavier Duval; Firas Al Kaied; Laura Iordache; Anne Gervais; Pascale Longuet; Françoise Blanchet; Gilles Peytavin; Catherine Leport


Pédagogie médicale | 2003

Conception de la sciences chez des étudiants en médecine français

Dominique Maillard; Françoise Blanchet; Maryline Coquide

Collaboration


Dive into the Françoise Blanchet's collaboration.

Top Co-Authors

Avatar

Maryline Coquide

École normale supérieure de Cachan

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jean-Yves Fagon

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge